Society for Endocrinology - a world-leading authority on hormones

News

Spironolactone prevents hyperkaleamia in transgender teens

09 Apr 2019



According to data, published in the Journal of the Endocrine Society, only 2.2% of transgender adolescents treated with spironolactone developed hyperkalemia after starting initiation therapy.

Healio